CN112353736A - Skin-care conditioning cream for repairing hormone face - Google Patents
Skin-care conditioning cream for repairing hormone face Download PDFInfo
- Publication number
- CN112353736A CN112353736A CN202010990149.4A CN202010990149A CN112353736A CN 112353736 A CN112353736 A CN 112353736A CN 202010990149 A CN202010990149 A CN 202010990149A CN 112353736 A CN112353736 A CN 112353736A
- Authority
- CN
- China
- Prior art keywords
- skin
- percent
- repairing
- hormone
- care conditioning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000005556 hormone Substances 0.000 title claims abstract description 68
- 229940088597 hormone Drugs 0.000 title claims abstract description 68
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 30
- 239000006071 cream Substances 0.000 title abstract description 6
- 239000000047 product Substances 0.000 claims abstract description 36
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 20
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 20
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 17
- 241001474374 Blennius Species 0.000 claims abstract description 16
- 238000000855 fermentation Methods 0.000 claims abstract description 16
- 230000004151 fermentation Effects 0.000 claims abstract description 16
- 229920001184 polypeptide Polymers 0.000 claims abstract description 16
- 239000013535 sea water Substances 0.000 claims abstract description 16
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 15
- 239000004475 Arginine Substances 0.000 claims abstract description 15
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 15
- 102000016359 Fibronectins Human genes 0.000 claims abstract description 15
- 108010067306 Fibronectins Proteins 0.000 claims abstract description 15
- 239000004472 Lysine Substances 0.000 claims abstract description 15
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 15
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 claims abstract description 15
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 claims abstract description 15
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 15
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000706 filtrate Substances 0.000 claims abstract description 15
- -1 glycosyl trehalose Chemical compound 0.000 claims abstract description 15
- 229940090813 madecassoside Drugs 0.000 claims abstract description 15
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 14
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 13
- 239000002131 composite material Substances 0.000 claims abstract description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 10
- 240000003538 Chamaemelum nobile Species 0.000 claims abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 32
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000008267 milk Substances 0.000 claims description 25
- 210000004080 milk Anatomy 0.000 claims description 25
- 235000013336 milk Nutrition 0.000 claims description 25
- 238000003756 stirring Methods 0.000 claims description 24
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 20
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 18
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 10
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 10
- 229940116224 behenate Drugs 0.000 claims description 10
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 claims description 10
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 10
- 229920001577 copolymer Polymers 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 10
- 229920000058 polyacrylate Polymers 0.000 claims description 10
- 239000011591 potassium Substances 0.000 claims description 10
- 229910052700 potassium Inorganic materials 0.000 claims description 10
- 229940032094 squalane Drugs 0.000 claims description 10
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 10
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 239000000230 xanthan gum Substances 0.000 claims description 10
- 235000010493 xanthan gum Nutrition 0.000 claims description 10
- 229920001285 xanthan gum Polymers 0.000 claims description 10
- 229940082509 xanthan gum Drugs 0.000 claims description 10
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 9
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims description 8
- 229940075529 glyceryl stearate Drugs 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 5
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims description 5
- 229940009868 aluminum magnesium silicate Drugs 0.000 claims description 5
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 229940104261 taurate Drugs 0.000 claims description 5
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- 244000060011 Cocos nucifera Species 0.000 claims description 2
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- 229940118127 fucus vesiculosus extract Drugs 0.000 claims description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 claims description 2
- 229940006284 undaria pinnatifida extract Drugs 0.000 claims description 2
- 244000044822 Simmondsia californica Species 0.000 claims 2
- 229940018958 sargassum fusiforme extract Drugs 0.000 claims 1
- 230000008439 repair process Effects 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 12
- 230000008591 skin barrier function Effects 0.000 abstract description 6
- 230000036074 healthy skin Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000004519 grease Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 104
- 206010000496 acne Diseases 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 244000042664 Matricaria chamomilla Species 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 241000221095 Simmondsia Species 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 238000005562 fading Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000037075 skin appearance Effects 0.000 description 4
- 230000004215 skin function Effects 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000628997 Flos Species 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229940014041 hyaluronate Drugs 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 240000002129 Malva sylvestris Species 0.000 description 2
- 235000006770 Malva sylvestris Nutrition 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000195474 Sargassum Species 0.000 description 2
- 230000000397 acetylating effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 101710199886 Protein 0.5 Proteins 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000006754 Taraxacum officinale Nutrition 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 244000137773 Viola philippica Species 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a skin-care conditioning emulsion for repairing hormone face, which comprises arginine/lysine polypeptide, chamomile hydrolat, madecassoside, seawater, fibronectin, a composite seaweed extract, sodium hyaluronate, glycosyl trehalose, oat beta-glucan, a secondary yeast fermentation product filtrate and osmin. The skin-care conditioning cream for repairing hormone faces strengthens skin barriers by balancing grease, repairing cells and moistening skin to improve the skin state, promotes the self-healing capability and toxin expelling of the skin, and realizes the repair of hormone faces under the synergistic effect of multiple effects; has good repairing effect on mild, moderate and severe hormone faces, is not easy to relapse, and can restore healthy skin.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a skin-care conditioning cream for repairing hormone face.
Background
With the improvement of the requirement of people on the beautifying speed, products such as quick acne removal, whitening, freckle removal, anti-aging and the like appear on the market, hormone components are added into part of the products for the purpose of instant product effect, and the hormone face can be caused to appear after the products are used for a long time. The hormone face is also called as hormone-dependent dermatitis (Cortisteroid adjuvant dermatitis), is dermatitis caused by long-term repeated and improper external application of drugs containing Corticosteroid hormones or skin care products such as quick-acting whitening and freckle removing products with illegally added hormones, and seriously damages the normal physiological structure and function of the skin. Once stopping taking the medicine, the original skin diseases can recur and aggravate, the ointment or the cosmetics are continuously used, the symptoms are rapidly relieved, and the symptoms are repeated after stopping taking the medicine, so that the vicious circle is formed.
The main manifestations of sensitive skin can be summarized as dry, itchy, swollen, painful, red. "hormonal faces" are manifested by polymorphic skin lesions such as erythema, papules, flushing, telangiectasia, dry desquamation, swelling, enlarged pores, pigment changes, acne-like or rosaceae-like symptoms; and the skin damage degree is serious, the skin damage attacks repeatedly and is stubborn and difficult to heal, and the health and the beauty of the skin are influenced. On the other hand, the skin barrier is completely destroyed, and mild causes can lead to allergic dermatitis, a hormone face.
Currently, the more traditional treatment regimen for treating hormone faces is to continue using hormone ointment in dermatology under the direction of a cosmetologist, gradually and slowly reducing the dose and stopping the dose to relieve the symptoms. The other is a naked face treatment method, namely, the skin is not washed, does not touch or touch and is not stimulated by any outside world, and the skin can freely develop along with the self metabolism of the skin; however, the naked face treatment method is only suitable for patients with mild disease, and the patients can recover within a few days, while the patients with severe disease need 3-5 years of repair time, and the repair time is too long.
Disclosure of Invention
The invention aims to provide a skin-care conditioning cream for repairing a hormone face, which aims to improve the hormone face and help repair the skin.
In order to achieve the purpose, the invention provides the following technical scheme:
the skin-care conditioning milk for repairing hormone face comprises the following raw materials in percentage by mass: arginine/lysine polypeptide 0.12-0.33%, chamomile pure water 0.7-2.6%, madecassoside 0.01-0.05%, sea water 0.2-0.85%, fibronectin 0.03-0.13%, composite seaweed extract 0.1-1%, sodium hyaluronate 0.04-0.12%, glycosyl trehalose 0.11-0.35%, oat beta-glucan 0.8-3.4%, yeast fermentation product filtrate 4.5-9.8%, and oshusuo 0.1-0.45%.
Preferably, the skin-care conditioning milk for repairing hormone face comprises the following raw materials in percentage by mass: arginine/lysine polypeptide 0.15-0.3%, chamomile pure water 1.5-2.5%, madecassoside 0.025-0.05%, sea water 0.3-0.65%, fibronectin 0.08-0.1%, composite seaweed extract 0.3-0.8%, sodium hyaluronate 0.05-0.1%, glycosyl trehalose 0.15-0.3%, oat beta-glucan 1.5-3%, yeast bifidus fermentation product filtrate 6-8%, and oshmannine 0.2-0.45%.
More preferably, the skin-care conditioning milk for repairing hormone faces further comprises the following raw materials in percentage by mass: 0.2 to 0.5 percent of coconut acyl hydrolyzed oat protein potassium, 0.2 to 0.5 percent of cetostearyl alcohol, 0.2 to 0.8 percent of glycerol stearate, 0.5 to 1 percent of glycerol oleate, 0.5 to 1 percent of polyglycerol-6 stearate, 0.5 to 1 percent of polyglycerol-6 behenate, 1 to 3 percent of squalane, 1 to 3 percent of jojoba seed oil, 1 to 3 percent of caprylic/capric triglyceride and 0.04 to 0.08 percent of xanthan gum, 60.05-0.08% of polyacrylate cross-linked polymer, 0.05-0.1% of acryloyl dimethyl taurate/VP copolymer, 0.3-0.55% of phenoxyethanol, 0.1-0.2% of p-hydroxyacetophenone, 1-2% of 1,2 pentanediol, 1-5% of glycerol, 1-5% of propylene glycol, 0.1-0.25% of magnesium aluminum silicate and deionized water to 100%.
A skin care milk for repairing hormone face is prepared from compound Sargassum extract including Undaria pinnatifida extract, Sargassum extract, and Fucus vesiculosus extract.
A skin care milk for repairing hormone face is prepared from sodium hyaluronate through acetylating.
A preparation method of skin-care conditioning milk for repairing hormone face comprises the following steps:
1) accurately weighing potassium cocoyl hydrolyzed oat protein, cetostearyl alcohol, glyceryl stearate, glyceryl oleate, polyglycerol-6 stearate, polyglycerol-6 behenate, squalane, jojoba seed oil 1-3%, and caprylic/capric triglyceride, placing in an oil phase pan, heating while stirring until completely dissolved, and keeping the temperature for 5-6min to obtain phase A;
2) accurately weighing xanthan gum, polyacrylate crosslinked polymer-6, acryloyl dimethyl ammonium taurate/VP copolymer, glycerol, propylene glycol, aluminum magnesium silicate and deionized water, placing in a water phase pot, heating while stirring until completely dissolving, and keeping the temperature for 5-6min to obtain phase B;
3) pouring the phase A into the phase B, homogenizing and emulsifying at the rotating speed of 3200-;
4) and (3) cooling the phase C to 40-45 ℃ while stirring, sequentially adding p-hydroxyacetophenone, 1,2 pentanediol, arginine/lysine polypeptide, chamomile hydrolat, madecassoside, seawater, fibronectin, a composite seaweed extract, sodium hyaluronate, glycosyl trehalose, oat beta-glucan, a yeast-bifida fermentation product filtrate and oshusuo, uniformly stirring, detecting qualified products and discharging to prepare the skin-care conditioning milk for repairing hormone faces.
Arginine/lysine polypeptide is a small molecular peptide derived from a genetic engineering fermentation technology, is a non-synthetic polypeptide, is non-animal collagen, repairs skin barriers, and improves sensitive muscles.
Madecassoside, a potent and highly pure active ingredient, is one of the main substances present in centella asiatica. Has antipruritic, anti-erythema and anti-desquamation effects, and can relieve sensitive skin, atopic dermatitis and psoriasis skin, and improve erythema, desquamation and roughness of skin.
The seawater is deep seawater which is permeated into geological layers with abundant nutrients and is balanced by nature, contains abundant mineral substances and trace elements, supplements the trace elements and mineral substances of the skin and enhances the cohesion of skin cells; can endow the skin with unlimited activity, glow and refresh the skin; active water, which can preserve moisture and enhance vitality and vitality of cells; the skin is shiny and glowing, and the skin quality is thoroughly improved; promoting penetration and absorption, enhancing toxin expelling and detoxifying capability of skin, resisting inflammation and allergy/repair, and thoroughly improving skin quality.
The sodium hyaluronate is acetylated sodium hyaluronate (AcHA) and is obtained by acetylating natural moisturizing factor sodium Hyaluronate (HA), so that the affinity and adsorbability of HA to skin are enhanced, and the moisturizing performance of HA is improved. The acetyl group is lipophilic, so that AcHA can be firmly adsorbed on the surface of the skin, has small molecular weight and can quickly permeate into the horny layer, so that the AcHA can reduce water loss on the surface of the skin and increase internal water accumulation, can permeate into the epidermis to hydrate and soften the horny layer, acts inside and outside simultaneously, plays a double moisturizing effect, can repair damaged epidermal cells, enhances the barrier of the horny layer, improves the dry and rough state of the skin, and enables the skin to be soft and elastic.
Fibronectin is a protein active substance widely existing in human bodies, plays a central role in cell adhesion, can regulate cell polarity, differentiation and growth, is widely involved in the processes of skin cell migration, proliferation, hemostasis, tissue repair and the like, regulates an immune cell system to remove harmful substances at the damaged tissue, has the functions of repair and inflammation resistance, has the similar function of growth factors, has the biological function of cell regeneration repair, but has mild action and no side effect; strengthening the stratum corneum, improving the resistance of the stratum corneum to external stimulation, guiding macromolecules to be absorbed through skin, permeating into the skin dermis, stimulating cells to generate nutrient substances (collagen, hyaluronic acid, small molecular peptides and the like), and promoting the metabolism of the cells; damaged and broken fibroblasts can be repaired more quickly, the smoothing of dynamic lines such as the eye circumference and the like is accelerated, and the depth of static lines such as few raised lines and the like is reduced; simultaneously has the functions of removing acne and lightening acne marks.
The seaweed extract is rich in methionine and cystine, integrates moisture retention and tightening performance, can regulate the secretion of dry and oily skin, regulate the water-oil balance of the skin, and effectively tighten and tighten skin pores; can reactivate 14 related genes in the extracellular matrix of the dermis layer, and restore the vitality of the skin, so that the skin is younger.
The oshusuo comprises water, glycerol, flos Matricariae Chamomillae (Chamomilla RECUTITA) flower extract, flos Malva sylvestris (MALVA SYLVESTRIS) flower extract, radix Paeoniae (Paeonia alba) root extract, flos Lonicerae (Lonicera JAPONICA) flower extract, herba Taraxaci (Taraxacum OFFICINALE) rhizome/root extract, herba Violae (Viola YEDOENSIS) extract, Aloe BARBADENSIS (Aloe BARBADENSIS) leaf juice, and ethylhexyl glycerol, plant allergy relieving essence extracted from various plants,
oat beta-glucan: the skin care product has the advantages of stimulating the growth of an immune system and fibroblasts, accelerating the movement of keratinocytes, promoting wound healing, promoting the synthesis of collagen and hyaluronic acid, improving the skin barrier repair function after laser dermabrasion, improving the powerful moisturizing effect, having the moisturizing effect superior to that of hyaluronic acid, helping to reduce wrinkles and rough skin, having good film forming property, protecting the skin from being damaged by external stimulation and leading the fresh and tender skin to grow healthily.
The glycosyl trehalose can form a protective film on the surface of skin, resist skin aging and keep skin vitality. The skin care product has the advantages of soothing and firming the skin, increasing the smoothness of the skin, moistening the skin, making the skin feel soft and giving the skin a smooth feeling. Can protect cells irradiated with ultraviolet rays, activate cells, maintain moisture, prevent skin dryness, and has anti-inflammatory effect.
Secondary split yeast fermentation product filtrate: the anti-aging active substance extracted from the lysate of the probiotics, namely bifidobacterium, by applying biotechnology can effectively protect skin from being damaged by ultraviolet rays, support the endogenous protection mechanism of the skin, resist skin premature senility, namely photoaging, promote cell repair by effectively activating the anti-immunosuppression process at the cellular level and promote cell regeneration, so that the resistance to adverse environmental influences is enhanced; because the skin regeneration speed is accelerated, the effects of removing wrinkles, repairing, moisturizing and enhancing the skin elasticity are exerted, the old cutin is removed, and the skin is white, tender and bright like molting.
Compared with the prior art, the invention has the beneficial effects that:
the face-care conditioning cream with the repairing hormone provided by the invention can nourish skin, promote blood circulation, cool and calm and relieve skin, repair hormone face, shrink pores, recover healthy skin and beautify skin. Inhibiting inflammatory reaction of skin, relieving adverse reaction symptom of skin, improving inflammation, and promoting repair of hormone face and removing toxic substance; activating cell genes, promoting the self-healing and repairing capability of skin, and recovering the healthy metabolism of skin; promoting epidermal cell proliferation, accelerating cell activity recovery, repairing damaged epidermal cells, promoting tissue regeneration, enhancing stratum corneum barrier function, and improving natural resistance of skin; the skin can be drunk with enough moisture to strengthen the skin barrier, adjust the water-oil balance of the skin and provide a good epidermal environment for skin repair.
Drawings
The above features and advantages of the present invention will become more apparent from the following detailed description when taken in conjunction with the accompanying drawings, in which:
FIG. 1 is a graph of water loss data showing that skin water loss can be reduced to enhance skin barrier function.
Detailed Description
The present invention will be described in further detail with reference to specific embodiments in the form of examples. It should not be understood that the scope of the above-described subject matter of the present invention is limited to the following examples.
Example 1
The skin-care conditioning milk for repairing hormone faces comprises the following raw materials in percentage by mass: arginine/lysine polypeptide 0.2%, chamomile hydrolat 2%, madecassoside 0.035%, sea water 0.45%, fibronectin 0.08%, composite seaweed extract 0.5%, sodium hyaluronate 0.1%, glycosyl trehalose 0.25%, oat beta-glucan 2%, yeast fermentation product filtrate 6.5%, oshmannine 0.4%, potassium cocoyl-hydrolyzed oat protein 0.35%, cetostearyl alcohol 0.2%, glyceryl stearate 0.5%, glyceryl oleate 0.6%, polyglyceryl-6 stearate 0.8%, polyglyceryl-6 behenate 0.8%, squalane 2%, jojoba seed oil 2.5%, caprylic/capric triglyceride 2%, xanthan gum 0.06%, polyacrylate cross-linked polymer-60.08%, ammonium acryloyldimethyl taurate/VP copolymer 0.08%, phenoxyethanol 0.4%, p-hydroxyacetophenone 0.15%, 1,2 pentanediol 1.5%, and, 4% of glycerin, 3% of propylene glycol, 0.15% of magnesium aluminum silicate and 100% of deionized water.
A preparation method of the skin-care conditioning milk comprises the following steps:
1) accurately weighing potassium cocoyl hydrolyzed oat protein, cetostearyl alcohol, glyceryl stearate, glyceryl oleate, polyglycerol-6 stearate, polyglycerol-6 behenate, squalane, jojoba seed oil 1-3% and caprylic/capric triglyceride, placing in an oil phase pot, heating while stirring until the mixture is completely dissolved, and keeping the temperature for 6min to obtain phase A;
2) accurately weighing xanthan gum, polyacrylate crosslinked polymer-6, acryloyl dimethyl ammonium taurate/VP copolymer, glycerol, propylene glycol, aluminum magnesium silicate and deionized water, placing in a water phase pot, heating while stirring until completely dissolved, and keeping the temperature for 6min to obtain phase B;
3) pouring the phase A into the phase B, homogenizing and emulsifying at 3800r/min for 5min, stirring for 8min to obtain phase C;
4) and (3) cooling the phase C to 43 ℃ while stirring, sequentially adding p-hydroxyacetophenone, 1, 2-pentanediol, arginine/lysine polypeptide, chamomile hydrosol, madecassoside, seawater, fibronectin, a composite seaweed extract, sodium hyaluronate, glycosyl trehalose, oat beta-glucan, a yeast-bifida fermentation product filtrate and oshusuo while stirring, uniformly stirring, detecting qualified products, and discharging to prepare the skin-care conditioning milk for repairing hormone faces.
Example 2
The skin-care conditioning milk for repairing hormone faces comprises the following raw materials in percentage by mass: arginine/lysine polypeptide 0.15%, chamomile hydrolat 1.5%, madecassoside 0.025%, sea water 0.3%, fibronectin 0.08%, complex seaweed extract 0.3%, sodium hyaluronate 0.05%, glycosyl trehalose 0.15%, oat beta-glucan 1.5%, yeast dehiscence fermentation product filtrate 6%, osmin 0.2%, potassium cocoyl hydrolyzed oat protein 0.2%, cetostearyl alcohol 0.2%, glyceryl stearate 0.2%, glyceryl oleate 0.5%, polyglycerol-6 stearate 0.5%, polyglycerol-6 behenate 0.5%, squalane 1%, jojoba seed oil 1%, caprylic/capric triglyceride 1%, xanthan gum 0.04%, polyacrylate cross-linked polymer-60.05%, ammonium acryloyldimethyl taurate/VP copolymer 0.05%, phenoxyethanol 0.3%, p-hydroxyacetophenone 0.1%, 1,2 pentanediol 1%, sodium alginate, sodium hyaluronate, sodium alginate, sodium, 1% of glycerol, 1% of propylene glycol, 0.1% of magnesium aluminum silicate and 100% of deionized water.
A preparation method of the skin-care conditioning milk comprises the following steps:
1) accurately weighing potassium cocoyl hydrolyzed oat protein, cetostearyl alcohol, glyceryl stearate, glyceryl oleate, polyglycerol-6 stearate, polyglycerol-6 behenate, squalane, jojoba seed oil 1-3% and caprylic/capric triglyceride, placing in an oil phase pot, heating while stirring until the mixture is completely dissolved, and keeping the temperature for 5min to obtain phase A;
2) accurately weighing xanthan gum, polyacrylate crosslinked polymer-6, acryloyl dimethyl ammonium taurate/VP copolymer, glycerol, propylene glycol, aluminum magnesium silicate and deionized water, placing in a water phase pot, heating while stirring until completely dissolving, and keeping the temperature for 5min to obtain phase B;
3) pouring the phase A into the phase B, homogenizing and emulsifying at 4200r/min for 3.5min, stirring for 8min to obtain phase C;
4) and (3) cooling the phase C to 40 ℃ while stirring, sequentially adding p-hydroxyacetophenone, 1, 2-pentanediol, arginine/lysine polypeptide, chamomile hydrosol, madecassoside, seawater, fibronectin, a composite seaweed extract, sodium hyaluronate, glycosyl trehalose, oat beta-glucan, a yeast-bifida fermentation product filtrate and oshusuo, uniformly stirring, detecting qualified products, and discharging to prepare the skin-care conditioning milk for repairing hormone faces.
Example 3
The skin-care conditioning milk for repairing hormone faces comprises the following raw materials in percentage by mass: arginine/lysine polypeptide 0.3%, chamomile hydrolat 2.5%, madecassoside 0.05%, sea water 0.65%, fibronectin 0.1%, complex seaweed extract 0.3-0.8%, sodium hyaluronate 0.1%, glycosyl trehalose 0.3%, oat beta-glucan 3%, yeast fermentation product filtrate 8%, osmin 0.45%, potassium cocoyl-hydrolyzed oat protein 0.5%, cetostearyl alcohol 0.5%, glyceryl stearate 0.8%, glyceryl oleate 1%, polyglyceryl-6 stearate 1%, polyglyceryl-6 behenate 1%, squalane 3%, jojoba seed oil 3%, caprylic/capric triglyceride 3%, xanthan gum 0.08%, polyacrylate crosspolymer-60.08%, ammonium acryloyldimethyl taurate/VP copolymer 0.1%, ethanol 0.55%, p-hydroxy-phenyl 0.2%, 1,2 percent of pentanediol 2 percent, 5 percent of glycerol, 5 percent of propylene glycol, 0.25 percent of magnesium aluminum silicate and deionized water to 100 percent.
A preparation method of skin-care conditioning milk for repairing hormone face comprises the following steps:
1) accurately weighing potassium cocoyl hydrolyzed oat protein, cetostearyl alcohol, glyceryl stearate, glyceryl oleate, polyglycerol-6 stearate, polyglycerol-6 behenate, squalane, jojoba seed oil 1-3% and caprylic/capric triglyceride, placing in an oil phase pot, heating while stirring until the mixture is completely dissolved, and keeping the temperature for 6min to obtain phase A;
2) accurately weighing xanthan gum, polyacrylate crosslinked polymer-6, acryloyl dimethyl ammonium taurate/VP copolymer, glycerol, propylene glycol, aluminum magnesium silicate and deionized water, placing in a water phase pot, heating while stirring until completely dissolved, and keeping the temperature for 6min to obtain phase B;
3) pouring the phase A into the phase B, homogenizing and emulsifying at 3200r/min for 6min, and stirring for 10min to obtain phase C;
4) and (3) cooling the phase C to 45 ℃ while stirring, sequentially adding p-hydroxyacetophenone, 1, 2-pentanediol, arginine/lysine polypeptide, chamomile hydrosol, madecassoside, seawater, fibronectin, a composite seaweed extract, sodium hyaluronate, glycosyl trehalose, oat beta-glucan, a yeast-bifida fermentation product filtrate and oshusuo, uniformly stirring, detecting qualified products, and discharging to prepare the skin-care conditioning milk for repairing hormone faces.
Comparative example 1
The difference from example 1 is that oat beta-glucan, yeast bifidus fermentation product filtrate were not added, other raw materials and preparation method were the same as example 1.
Comparative example 2
The difference from example 1 is that the complex seaweed extract, sea water, fibronectin were not added, and other raw materials and preparation methods were the same as example 1.
Comparative example 3
The difference from example 1 is that arginine/lysine polypeptide and madecassoside are not added, and other raw materials and preparation methods are the same as example 1.
Efficacy verification
The hormone face skin was selected for a total of 600 cases. Wherein, the skin of the mild hormone face comprises 200 cases, the skin of the moderate hormone face comprises 200 cases, and the skin of the severe hormone face comprises 200 cases. The treatment groups 1,2, 3, 1,2 and 3 were divided into 4 groups, 100 of which had the same number of mild, moderate and severe hormone facial skin cases. Treatment group 1 hormone facial restoration was performed using the product prepared in example 1; treatment group 2 hormone face treatment was performed using the product prepared in example 2; treatment group 3 hormone face treatment was performed using the product prepared in example 3. Control group 1 was treated with hormone face using the product prepared in comparative example 1; control group 2 was treated with hormone face using the product prepared in comparative example 2; control group 3 was subjected to hormone face treatment using the product prepared in comparative example 3. The using method comprises the following steps: after cleansing the face every morning and evening, the products of examples 1 to 3 and comparative examples 1 to 3 were applied uniformly to the facial skin and absorbed by patting with finger bells.
The curative effect standard is as follows:
the effect is shown: after 1h, the symptoms of skin redness, itching and pain disappear.
For mild hormone face skin, after 1 day of use, pimples become small and basically disappear, and skin surface inflammation gradually disappears; after 3 days of use, most hormone faces can be subjected to the withdrawal phenomenon with different degrees, and the symptoms are red, swollen, itchy and papule; after 5 days of use, the skin in the withdrawal period shows red, swelling, pimple and exudation symptoms which are gradually faded, and the appearance of the skin mainly shows dryness and skin fading and gradually approaches to normal; after insisting on using for 15 days, the appearance and the function of the skin are almost recovered to be normal. No recurrence within half a year.
For the moderate hormone face skin, after 2 days of use, erythema, pimple become small, red and swollen parts basically disappear, and skin surface inflammation gradually disappears. After 4 days of use, most hormone faces will be withdrawn with different degrees, which is manifested as red, swollen, itchy and papule. After 8 days of use, the skin in the withdrawal period shows red, swelling, pimple and exudation symptoms which are gradually faded, and the appearance of the skin mainly shows dryness and skin fading and gradually approaches to normal; after 25 days of use, skin appearance and function were nearly normal. No recurrence within half a year.
For severe hormone face skin, after 3 days, the pimple is seriously swollen, the large blister is small, the red swelling part basically disappears, and the skin surface inflammation gradually disappears. After 8 days of use, most hormone faces will be in different degrees of withdrawal, blisters and exudation. After 15 days of use, the skin in the withdrawal period shows red, swollen, pimple and exudation symptoms which are gradually faded, and the appearance of the skin mainly shows dryness and skin fading and gradually approaches to normal; after 38 days of use, skin appearance and function were nearly normal. No recurrence within half a year.
The method has the following advantages: after 2 hours of use, the symptoms of skin redness, itching and pain disappear.
For mild hormone face skin, after 2 days of use, the pimple becomes small and basically disappears, and the inflammation on the surface of the skin gradually disappears; after 5 days of use, most hormone faces can be subjected to the withdrawal phenomenon with different degrees, and the symptoms are red, swollen, itchy and papule; after 7 days of use, the skin in the withdrawal period shows red, swelling, pimple and exudation symptoms which are gradually faded, and the appearance of the skin mainly shows dryness and skin fading and gradually approaches to normal; after insisting on using for 20 days, the appearance and the function of the skin are almost recovered to be normal. No recurrence within half a year.
For the moderate hormone face skin, after 3 days of use, erythema, pimple become small, red and swollen parts basically disappear, and skin surface inflammation gradually disappears. After 6 days of use, most hormone faces will be in different degrees of withdrawal, which is manifested as red, swollen, itchy and papular. After 10 days of use, the skin in the withdrawal period shows red, swelling, pimple and exudation symptoms which are gradually faded, and the appearance of the skin mainly shows dryness and skin fading and gradually approaches to normal; after 30 days of use, skin appearance and function were nearly normal. No recurrence within half a year.
For severe hormone face skin, after 4 days of use, the pimple is seriously swollen, the blister is small, the red swelling part basically disappears, and the skin surface inflammation gradually disappears; after 13 days of use, most hormone faces will be in different degrees of withdrawal, blisters and exudation. After 18 days of use, the skin in the withdrawal period shows red, swollen, pimple and exudation symptoms which are gradually faded, and the appearance of the skin mainly shows dryness and skin fading and gradually approaches to normal; after 45 days of use, skin appearance and function were nearly normal. No recurrence within half a year.
And (4) invalidation: after 3 days of use, there was no change or more severe skin symptoms. Or recurrent hair within half a year.
As a result:
item | Number of examples | Significant effects/examples | Effective/example | Invalid/example | Total effective rate/%) |
Example 1 | 100 examples of | 59 | 40 | 1 | 99 |
Example 2 | 100 examples of | 45 | 49 | 6 | 94 |
Example 3 | 100 examples of | 42 | 51 | 7 | 93 |
Comparative example 1 | 100 examples of | 25 | 35 | 40 | 60 |
Comparative example 2 | 100 examples of | 23 | 38 | 45 | 61 |
Comparative example 3 | 100 examples of | 35 | 42 | 27 | 77 |
And (4) conclusion: the data in the table show that compared with the comparative example, the examples have better hormone face repairing effect, have better repairing effect on mild, moderate and severe hormone faces, and obviously fine and smooth skin pores.
TEWL test
The water dispersion loss (TEWL) of the skin of the subject was measured separately using a test instrument, Tewameter TM3000, after the product was applied by the volunteers.
And (4) conclusion: as can be seen from the data in figure 1, the repair hormone facial skin care conditioning milk provided by the invention can improve the water retention function of skin, reduce the water dispersion amount of the skin, continuously supplement water for the skin and enhance the barrier function of the skin.
Although the preferred embodiments of the present patent have been described in detail, the present patent is not limited to the above embodiments, and various changes can be made without departing from the spirit of the present patent within the knowledge of those skilled in the art.
Claims (6)
1. The skin-care conditioning milk for repairing hormone faces is characterized by comprising the following raw materials in percentage by mass: arginine/lysine polypeptide 0.12-0.33%, chamomile pure water 0.7-2.6%, madecassoside 0.01-0.05%, sea water 0.2-0.85%, fibronectin 0.03-0.13%, composite seaweed extract 0.1-1%, sodium hyaluronate 0.04-0.12%, glycosyl trehalose 0.11-0.35%, oat beta-glucan 0.8-3.4%, yeast fermentation product filtrate 4.5-9.8%, and oshusuo 0.1-0.45%.
2. The skin-care conditioning milk for repairing hormone faces, according to claim 1, is characterized by comprising the following raw materials in percentage by mass: arginine/lysine polypeptide 0.15-0.3%, chamomile pure water 1.5-2.5%, madecassoside 0.025-0.05%, sea water 0.3-0.65%, fibronectin 0.08-0.1%, composite seaweed extract 0.3-0.8%, sodium hyaluronate 0.05-0.1%, glycosyl trehalose 0.15-0.3%, oat beta-glucan 1.5-3%, yeast bifidus fermentation product filtrate 6-8%, and oshmannine 0.2-0.45%.
3. The skin care conditioning milk for repairing hormone faces as claimed in claim 1, further comprising the following raw materials by mass percent: 0.2 to 0.5 percent of coconut acyl hydrolyzed oat protein potassium, 0.2 to 0.5 percent of cetostearyl alcohol, 0.2 to 0.8 percent of glycerol stearate, 0.5 to 1 percent of glycerol oleate, 0.5 to 1 percent of polyglycerol-6 stearate, 0.5 to 1 percent of polyglycerol-6 behenate, 1 to 3 percent of squalane, 1 to 3 percent of jojoba seed oil, 1 to 3 percent of caprylic/capric triglyceride and 0.04 to 0.08 percent of xanthan gum, 60.05-0.08% of polyacrylate cross-linked polymer, 0.05-0.1% of acryloyl dimethyl taurate/VP copolymer, 0.3-0.55% of phenoxyethanol, 0.1-0.2% of p-hydroxyacetophenone, 1-2% of 1,2 pentanediol, 1-5% of glycerol, 1-5% of propylene glycol, 0.1-0.25% of magnesium aluminum silicate and deionized water to 100%.
4. The skin care conditioning milk for repairing hormone face as claimed in any one of claims 1-2, wherein the compound seaweed extract comprises two or more of Undaria pinnatifida extract, Sargassum fusiforme extract, and Fucus vesiculosus extract.
5. The skin care conditioning milk for repairing hormone face according to any one of claims 1-2, wherein the sodium hyaluronate is acetylated sodium hyaluronate.
6. The skin care conditioning milk for repairing hormone face according to any one of claims 1 to 3, characterized in that the preparation method of the skin care conditioning milk comprises the following steps:
1) accurately weighing potassium cocoyl hydrolyzed oat protein, cetostearyl alcohol, glyceryl stearate, glyceryl oleate, polyglycerol-6 stearate, polyglycerol-6 behenate, squalane, jojoba seed oil 1-3%, and caprylic/capric triglyceride, placing in an oil phase pan, heating while stirring until completely dissolved, and keeping the temperature for 5-6min to obtain phase A;
2) accurately weighing xanthan gum, polyacrylate crosslinked polymer-6, acryloyl dimethyl ammonium taurate/VP copolymer, glycerol, propylene glycol, aluminum magnesium silicate and deionized water, placing in a water phase pot, heating while stirring until completely dissolving, and keeping the temperature for 5-6min to obtain phase B;
3) pouring the phase A into the phase B, homogenizing and emulsifying at the rotating speed of 3200-;
4) and (3) cooling the phase C to 40-45 ℃ while stirring, sequentially adding p-hydroxyacetophenone, 1,2 pentanediol, arginine/lysine polypeptide, chamomile hydrolat, madecassoside, seawater, fibronectin, a composite seaweed extract, sodium hyaluronate, glycosyl trehalose, oat beta-glucan, a yeast-bifida fermentation product filtrate and oshusuo, uniformly stirring, detecting qualified products and discharging to prepare the skin-care conditioning milk for repairing hormone faces.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010990149.4A CN112353736A (en) | 2020-09-18 | 2020-09-18 | Skin-care conditioning cream for repairing hormone face |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010990149.4A CN112353736A (en) | 2020-09-18 | 2020-09-18 | Skin-care conditioning cream for repairing hormone face |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112353736A true CN112353736A (en) | 2021-02-12 |
Family
ID=74516618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010990149.4A Pending CN112353736A (en) | 2020-09-18 | 2020-09-18 | Skin-care conditioning cream for repairing hormone face |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112353736A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113133967A (en) * | 2021-04-29 | 2021-07-20 | 厦门力嘉诚生物科技有限公司 | Peony essence skin-moistening facial cream and preparation method thereof |
CN113398031A (en) * | 2021-07-09 | 2021-09-17 | 广州颜芝堡化妆品有限公司 | Multifunctional mask liquid and preparation method thereof |
CN113693962A (en) * | 2021-08-09 | 2021-11-26 | 深圳市护家科技有限公司 | Fibronectin-containing multiple protein repair composition and preparation method thereof |
CN114246818A (en) * | 2021-03-08 | 2022-03-29 | 山东祥隆医药研究院有限公司 | Essence milk with allergy preventing, moisturizing and repairing effects and preparation method thereof |
CN114259453A (en) * | 2022-01-20 | 2022-04-01 | 中科东方细胞科技有限公司 | Sensitive muscle relieving and repairing spray and preparation method and application thereof |
CN115590797A (en) * | 2022-10-19 | 2023-01-13 | 广东柏俐臣生物科技有限公司(Cn) | Firming and anti-wrinkle face cream containing bistort rhizome extract and preparation method thereof |
CN115634169A (en) * | 2022-04-27 | 2023-01-24 | 广州市万千粉丝化妆品有限公司 | Application of extracellular matrix beta-myoglycan protein in cosmetics for repairing hormone-dependent skin |
CN115944576A (en) * | 2022-11-21 | 2023-04-11 | 烟台新时代健康产业日化有限公司 | Composition for repairing sensitive skin, mask liquid and mask |
CN117224454A (en) * | 2023-11-16 | 2023-12-15 | 成都普什制药有限公司 | Anti-aging/anti-saccharification essence and preparation method thereof |
-
2020
- 2020-09-18 CN CN202010990149.4A patent/CN112353736A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114246818A (en) * | 2021-03-08 | 2022-03-29 | 山东祥隆医药研究院有限公司 | Essence milk with allergy preventing, moisturizing and repairing effects and preparation method thereof |
CN113133967A (en) * | 2021-04-29 | 2021-07-20 | 厦门力嘉诚生物科技有限公司 | Peony essence skin-moistening facial cream and preparation method thereof |
CN113398031A (en) * | 2021-07-09 | 2021-09-17 | 广州颜芝堡化妆品有限公司 | Multifunctional mask liquid and preparation method thereof |
CN113693962A (en) * | 2021-08-09 | 2021-11-26 | 深圳市护家科技有限公司 | Fibronectin-containing multiple protein repair composition and preparation method thereof |
CN114259453A (en) * | 2022-01-20 | 2022-04-01 | 中科东方细胞科技有限公司 | Sensitive muscle relieving and repairing spray and preparation method and application thereof |
CN115634169A (en) * | 2022-04-27 | 2023-01-24 | 广州市万千粉丝化妆品有限公司 | Application of extracellular matrix beta-myoglycan protein in cosmetics for repairing hormone-dependent skin |
CN115590797A (en) * | 2022-10-19 | 2023-01-13 | 广东柏俐臣生物科技有限公司(Cn) | Firming and anti-wrinkle face cream containing bistort rhizome extract and preparation method thereof |
CN115944576A (en) * | 2022-11-21 | 2023-04-11 | 烟台新时代健康产业日化有限公司 | Composition for repairing sensitive skin, mask liquid and mask |
CN117224454A (en) * | 2023-11-16 | 2023-12-15 | 成都普什制药有限公司 | Anti-aging/anti-saccharification essence and preparation method thereof |
CN117224454B (en) * | 2023-11-16 | 2024-02-23 | 成都普什制药有限公司 | Anti-aging/anti-saccharification essence and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112353736A (en) | Skin-care conditioning cream for repairing hormone face | |
CN106511220A (en) | Dendrobium officinale moisturizing and repair sleeping mask and preparation method thereof | |
KR20170083068A (en) | Skincare formulations and regimens | |
CN111329782A (en) | Skin care product containing ceramide composition and preparation method thereof | |
CN112773761B (en) | Cosmetic composition, essence and preparation method thereof | |
WO2008139182A2 (en) | Skin care composition | |
CN115137665A (en) | Composition with long-acting moisturizing and relieving effects and application thereof | |
CN111973508A (en) | Anti-aging composition capable of relieving and moisturizing | |
CN106038337B (en) | Anti-acne skin makeup liquid and its preparation method | |
CN114632045B (en) | An anti-aging composition and its preparation method and application | |
CN114712285B (en) | Composition with anti-wrinkle effect and preparation method and application thereof | |
CN113368018A (en) | Anti-inflammatory acne-removing composition and preparation method thereof | |
CN110755332A (en) | Essence capable of replenishing water, whitening skin and removing freckles and preparation method of essence | |
CN109044941B (en) | Skin firming, nourishing and moisturizing composition and preparation method and application thereof | |
CN115024991B (en) | Anti-aging composition and preparation method and application thereof | |
CN107157830A (en) | Buttocks compacts formula, preparation method and application method | |
CN111012699A (en) | Antioxidant oil-controlling emulsion containing fucoidan-kelp extract | |
CN113384482B (en) | Moisturizing and skin-tendering essence and preparation method thereof | |
CN111514055A (en) | Cosmetic polypeptide composition granules with anti-inflammatory repair effect | |
CN113797153A (en) | Composition for effectively relieving skin allergy red blood streak and preparation method and application thereof | |
CN112807238A (en) | Anti-inflammatory and soothing repair gel for skin and preparation method thereof | |
CN112089674A (en) | Caviar muscle factor restoration essence and preparation method thereof | |
CN111419770A (en) | Moisturizing and repairing type temperature-sensitive awakening facial mask and preparation method thereof | |
CN112057386A (en) | Refreshing, moisturizing, whitening and repairing sun block and preparation method thereof | |
CN114053181A (en) | Anti-wrinkle composition and application thereof in skin care products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210212 |
|
WD01 | Invention patent application deemed withdrawn after publication |